SCHEMBL12465635

SCHEMBL12465635

C[C@@H]1C[C@H](N(Cc2ccccc2)Cc2ccccc2)CC[C@H]1NC(=O)OC(C)(C)C.C[C@H]1C[C@@H](N(Cc2ccccc2)Cc2ccccc2)CC[C@@H]1NC(=O)O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
MAOB P27338 2/20 0.45
KDM1A O60341 2/20 0.45
AKT1 P31749 3/20 0.43
JAK2 O60674 1/20 0.40
JAK1 P23458 1/20 0.40
CTSL P07711 2/20 0.40
CTSB P07858 2/20 0.40
CTSS P25774 2/20 0.40
REN P00797 1/20 0.40
CPB1 P15086 1/20 0.40
PDE4B Q07343 1/20 0.39
MAOA P21397 1/20 0.38
EPHX2 P34913 1/20 0.38
DPP8 Q6V1X1 1/20 0.38
DPP7 Q9UHL4 1/20 0.38
CA12 O43570 1/20 0.37
CA1 P00915 1/20 0.37
CA7 P43166 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14828563 0.90 DPP8 (0.44) KMT2ACPB1MAOADPP8DPP7
SCHEMBL14828562 0.90 DPP8 (0.44) KMT2ACPB1MAOADPP8DPP7
SCHEMBL14828519 0.90 DPP8 (0.44) KMT2ACPB1MAOADPP8DPP7
SCHEMBL14828564 0.90 DPP8 (0.44) KMT2ACPB1MAOADPP8DPP7
SCHEMBL14828520 0.90 DPP8 (0.44) KMT2ACPB1MAOADPP8DPP7
SCHEMBL14828517 0.90 DPP8 (0.44) KMT2ACPB1MAOADPP8DPP7
SCHEMBL31520824 0.81 KDM1A (0.57) KMT2AL3MBTL1MAOBKDM1AAKT1
SCHEMBL21071384 0.81 KDM1A (0.57) KMT2AL3MBTL1MAOBKDM1AAKT1
SCHEMBL6863653 0.81 KDM1A (0.57) KMT2AL3MBTL1MAOBKDM1AAKT1
SCHEMBL31352204 0.77 KMT2A (0.46) KMT2AL3MBTL1MAOBKDM1AAKT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2668162-A1 SUBSTITUTED BI-HETEROARYL COMPOUNDS AS CDK9 INHIBITORS AND THEIR USES Novartis AG (CH) 2013-12-04 EP disclosed
WO-2012101065-A2 PYRIMIDINE BIARYL AMINE COMPOUNDS AND THEIR USES NOVARTIS AG (CH) 2012-08-02 WO disclosed
WO-2012101066-A1 PYRIDINE BIARYL AMINE COMPOUNDS AND THEIR USES NOVARTIS AG (CH) 2012-08-02 WO disclosed
WO-2012101062-A1 SUBSTITUTED BI-HETEROARYL COMPOUNDS AS CDK9 INHIBITORS AND THEIR USES NOVARTIS AG (CH) 2012-08-02 WO disclosed